Press release
Key Companies Leading Innovation and Growth in the Gastroretentive Drug Delivery Systems Outsourcing Market
Gastroretentive Drug Delivery Systems Outsourcing Market
Growth Outlook and Market Size for the Gastroretentive Drug Delivery Systems Outsourcing Market
The gastroretentive drug delivery systems outsourcing market is projected to reach a valuation of $2.1 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 6.9% over the forecast period. Several factors contribute to this upward trend, including the increasing complexity of drug compounds, a growing emphasis on patient-centric delivery systems, broader adoption of outsourcing by pharmaceutical companies, technological advancements in gastroretentive platforms, and cost reduction initiatives. Key trends shaping the market involve expanded outsourcing of advanced drug delivery development, heightened demand for formulations with extended gastrointestinal retention, increased use of floating drug delivery systems, broadening contract research organization (CRO) collaborations, and a focus on improving drug bioavailability.
Download a free report of the gastroretentive drug delivery systems outsourcing market report:
https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Prominent Companies Leading the Gastroretentive Drug Delivery Systems Outsourcing Market
The market features a range of major players actively driving innovation and development, such as Pfizer Inc., Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, Evonik Industries AG, SGS SA, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc., Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Coating Place Inc., Xiromed LLC, and SPI Pharma Inc.
Strategic Acquisition to Strengthen Capabilities in the Gastroretentive Outsourcing Market
In January 2027, Kyowa Kirin Co., Ltd., a pharmaceutical company based in Japan, acquired Orchard Therapeutics plc., a UK-based gene therapy firm, for an undisclosed sum. This acquisition was aimed at enhancing Kyowa Kirin's portfolio by leveraging Orchard Therapeutics' expertise in gene therapy, particularly focused on developing treatments for rare and complex diseases. This move aligns with Kyowa Kirin's strategic focus on innovation and advanced therapeutic solutions.
View the full gastroretentive drug delivery systems outsourcing market report:
https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Emerging Trends Influencing the Gastroretentive Drug Delivery Systems Outsourcing Market
Leading companies within the market are concentrating on developing sophisticated diagnostic tools and delivery solutions to improve patient care. For instance, advancements in cardiovascular risk assessment have led to innovations such as Lp(a)-based assays, which enable precise measurement of lipoprotein(a) levels to help clinicians better stratify risk and customize treatments.
In May 2024, F. Hoffmann-La Roche AG, a Swiss biotechnology and diagnostics leader, introduced the Tina-quant Lp(a) RxDx assay after securing FDA Breakthrough Device Designation. This assay quantifies Lp(a) molecules per liter in blood, offering a standardized biomarker that enhances diagnostic accuracy for cardiovascular risk. Integrated with Roche's serum work area (SWA) systems and cobas® platforms, this innovation aids healare providers in making data-driven decisions regarding Lp(a)-lowering therapies, supporting personalized cardiovascular care and improving patient outcomes.
Segment Breakdown of the Gastroretentive Drug Delivery Systems Outsourcing Market
This market is divided into several important segments to provide detailed insights:
1) By Type: Floating Systems, Bioadhesive Systems, Other Types
2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms
3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications
4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users
Further subcategories include:
- Floating Systems: Single Unit Systems, Multiple Unit Systems
- Bioadhesive Systems: Hydrogels, Mucoadhesive Polymers
- Other Types: Magnetically Assisted Systems, High-Density Systems, Osmotic Systems
These classifications help clarify market dynamics and target areas for development and investment.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Companies Leading Innovation and Growth in the Gastroretentive Drug Delivery Systems Outsourcing Market here
News-ID: 4480112 • Views: …
More Releases from The Business Research Company
Precision Medicine Software Market Overview: Major Segments, Strategic Developme …
The precision medicine software market is gaining significant traction as personalized healthcare becomes increasingly important. With advancements in technology and growing investments in targeted therapies, this sector is poised for substantial expansion. Let's explore the market's projected valuation, key players, main driving forces, current trends, and detailed segments shaping its future.
Forecasted Market Value and Growth of the Precision Medicine Software Market
The precision medicine software market is set to grow…
Segmentation, Major Trends, and Competitive Analysis of the Postpartum Depressio …
The postpartum depression treatment sector is poised for significant expansion as awareness and innovations in maternal mental health continue to advance. With growing attention to personalized care and digital solutions, the market is set to evolve rapidly in the coming years. Let's explore the market size projections, key players, emerging trends, and detailed segmentation driving this vital healthcare field.
Projected Growth Trajectory of the Postpartum Depression Treatment Market
The global postpartum…
Leading Firms Advancing Innovation and Growth in the Postmenopausal Osteoporosis …
The postmenopausal osteoporosis treatment market is on track for significant expansion over the coming years. With advances in therapeutic options and a growing focus on personalized care, this sector is expected to undergo notable changes that will shape how osteoporosis is managed in postmenopausal women by 2030.
Forecasted Growth and Market Size of the Postmenopausal Osteoporosis Treatment Market
The market for postmenopausal osteoporosis treatments is projected to reach a value of…
Global Drivers Analysis: The Rapid Evolution of the Portable Vascular Doppler Ma …
The portable vascular doppler market is on track for significant expansion as advancements in medical technology continue to evolve. Increasing demand for accessible and efficient vascular diagnostic tools is driving interest among healthcare providers, leading to promising growth opportunities in this specialized segment. Let's explore the market's size, key players, emerging trends, and detailed segmentation to better understand the industry's trajectory.
Projected Market Size and Growth Outlook for the Portable Vascular…
More Releases for Gastroretentive
Emerging Gastroretentive Drug Delivery Systems Outsourcing Market Trends: Innova …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Gastroretentive Drug Delivery Systems Outsourcing Market Size Growth Forecast: What to Expect by 2025?
The market for outsourced gastroretentive drug delivery systems has seen remarkable growth in recent years. The market is projected to expand from $1.39 billion in 2024 to $1.5 billion in 2025, exhibiting a compound annual…
Rising Prevalence Of Gastrointestinal Disorders Drives Growth In Gastroretentive …
The Gastroretentive Drug Delivery Systems Outsourcing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Gastroretentive Drug Delivery Systems Outsourcing Market Size and Its Estimated Growth Rate?
The gastroretentive drug delivery systems outsourcing market has shown strong growth in recent years. It will…
Gastroretentive Drug Delivery Systems Outsourcing Market Expands as Bioavailabil …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Gastroretentive Drug Delivery Systems Outsourcing Market- (By Dosage Form (Tablets, Liquid, Microspheres, Capsule, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Gastroretentive Drug Delivery Systems Outsourcing Market is valued at US$ 1.26 Bn in 2022, and it is expected to reach US$ 2.32 Bn…
Top Factor Driving Gastroretentive Drug Delivery Systems Outsourcing Market Grow …
Which drivers are expected to have the greatest impact on the over the gastroretentive drug delivery systems outsourcing market's growth?
The increasing incidence of gastrointestinal disorders is expected to boost the growth of the gastroretentive drug delivery systems outsourcing market. Gastrointestinal disorders are on the rise due to factors like aging populations, antibiotic use, changes, and obesity. Outsourcing gastroretentive drug delivery systems allows pharmaceutical companies to address the growing demand…
Rising Prevalence Of Gastrointestinal Disorders Drives Growth In Gastroretentive …
How Will the Gastroretentive Drug Delivery Systems Outsourcing Market Grow, and What Is the Projected Market Size?
In recent times, the market size for outsourcing of gastroretentive drug delivery systems has expanded significantly. Projected growth estimates indicate an increase from $1.39 billion in 2024 to $1.5 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.3%. Several factors have contributed to this growth during the historic period, including a…
Gastroretentive Drug Delivery Systems Market Outlook 2029: Presents Market Insig …
The global gastroretentive drug delivery systems market is anticipated to grow at a CAGR of around 6.3% during the forecast period. The rising prevalence of functional gastrointestinal disorders (FGIDs), and gastric disorders majorly among the geriatric population globally is the major factor augmenting the growth of the gastroretentive drug delivery systems. The aged population is more susceptible to long-standing conditions such as dyspepsia, irritable bowel syndrome, inflammatory bowel disease (Crohn's disease and…
